Scientists are exploring a new approach to treating autoimmune diseases by targeting and resetting certain cells. This approach, which may involve CAR-T therapy, has shown promise in potentially leading to long-term disease remission. The treatment is being tested in trials, including one in the UK where a patient with multiple sclerosis has received CAR T-cell therapy.